Dear Members, On 8th September of 2022, the U.S. Food and Drug Administration (FDA) posted a Safety Communication on their website (https://www.fda.gov/medical-devices/safety-communications/breast-implants-reports-squamous-cell-carcinoma-and-various-lymphomas-capsule-around-implants-fda), informing the public about reports of cancers, including breast implant associated squamous cell carcinoma (BIA-SCC) and various lymphomas (besides BIA-ALCL) in the capsule surrounding breast implants. BIA-SCC has been reported as occurring in the capsule around both textured and smooth surfaces as well as in the capsule around both silicone and saline filled breast implants. Case reports, although very rare, have been published for several decades. So far, 26 cases have been reported worldwide. Based upon the literature,…
In this dark moment of history, EASAPS wants to declare…
This handbook has been prepared by EASAPS patient safety committee…
[pdf-embedder url="https://www.easaps.org/wp-content/uploads/2020/12/scheer-report-easaps.pdf" title="Scheer report EASAPS"]
[pdf-embedder url="https://www.easaps.org/wp-content/uploads/2020/03/BII-EASAPS.pdf" title="BII-EASAPS"]
[pdf-embedder url="https://www.easaps.org/wp-content/uploads/2020/05/Final-Easaps_espras-considerations.pdf" title="Final Easaps_espras considerations"]
Please read the statement from EASAPS/ESAPS regarding the recall of…
The latest videos from our members from all over Europe
ESAPS © 2017 - 2023 EASAPS European Society of Aesthetic Plastic Surgery. All right reserved.